Your Comments On...

Drug Firms' Deals Allowing Exclusivity

Brand-name drug companies have resumed the practice of slowing the sale of cheaper generic competitors by cutting deals that result in paying millions of dollars to makers of generic drugs while consumers continue to pay brand-name prices.
 - 

By Marc Kaufman